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Background: Gene-environment interactions are mediated by epigenetic mechanisms. Polycomb Group proteins
constitute part of an epigenetic cellular transcriptional memory system that is subject to dynamic modulation
during differentiation. Molecular insight in processes that control dynamic chromatin association and dissociation of
Polycomb repressive complexes during and beyond development is limited. We recently showed that MK3 interacts
with Polycomb repressive complex 1 (PRC1). The functional relevance of this interaction, however, remained poorly
understood. MK3 is activated downstream of mitogen- and stress-activated protein kinases (M/SAPKs), all of which
fulfill crucial roles during development. We here use activation of the immediate-early response gene ATF3, a bona
fide PRC1 target gene, as a model to study how MK3 and its effector kinases MAPK/ERK and SAPK/P38 are involved
in regulation of PRC1-dependent ATF3 transcription.
Results: Our current data show that mitogenic signaling through ERK, P38 and MK3 regulates ATF3 expression by
PRC1/chromatin dissociation and epigenetic modulation. Mitogenic stimulation results in transient P38-dependent
H3S28 phosphorylation and ERK-driven PRC1/chromatin dissociation at PRC1 targets. H3S28 phosphorylation by
itself appears not sufficient to induce PRC1/chromatin dissociation, nor ATF3 transcription, as inhibition of MEK/ERK
signaling blocks BMI1/chromatin dissociation and ATF3 expression, despite induced H3S28 phosphorylation. In
addition, we establish that concomitant loss of local H3K27me3 promoter marking is not required for ATF3
activation. We identify pERK as a novel signaling-induced binding partner of PRC1, and provide evidence that MK3
controls ATF3 expression in cultured cells via negative regulatory feedback on M/SAPKs. Dramatically increased
ectopic wing vein formation in the absence of Drosophila MK in a Drosophila ERK gain-of-function wing vein
patterning model, supports the existence of MK-mediated negative feedback regulation on pERK.
Conclusion: We here identify and characterize important actors in a PRC1-dependent epigenetic signal/response
mechanism, some of which appear to be nonspecific global responses, whereas others provide modular specificity.
Our findings provide novel insight into a Polycomb-mediated epigenetic mechanism that dynamically controls
gene transcription and support a direct link between PRC1 and cellular responses to changes in the
microenvironment.
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Mitogen- and stress-activated protein kinase (M/SAPK)
signaling pathways relay environment-to-gene informa-
tion and enable physiologically appropriate cellular
responses [1]. MK3 is an interaction partner of extracel-
lular signal-regulated kinase (ERK) and P38 and is tar-
geted by all three M/SAPK signaling cascades [2]; these
phosphorylation cascades induce multiple responses,
among which is altered gene transcription [3,4].
We previously demonstrated that mitogen-activated
protein kinase-activated protein kinase 3 (MK3/3pK/
MAPKAPK3) binds Polycomb repressive complex 1
(PRC1), via the self-association motif (SAM)-domain of
PHC [5]. Polycomb Group and Trithorax Group pro-
teins maintain transcriptionally repressed and activated
epigenetic states respectively and as such are part of an
important cellular transcriptional memory system. Al-
though PRC1-mediated transcriptional repression has
long been considered a stable repressive state, increasing
evidence indicates that PRC1 repression is a dynamic
process [6,7]. Genome-wide chromatin association studiesFigure 1 PRC1 target gene expression is controlled by M/SAPKs. (A,B)
(FCS/TPA) TIG3 cells, in the absence or presence of kinase inhibitors; data ±
U2-OS cells; DAPI: nuclear counterstain. (D) Subcellular PRC1 protein distrib
chromatin-bound fractions were proportionally loaded; nuclear fractions co
Cytoplasmic and nuclear fractions were always loaded on the same gel for
separately; representative experiment shown). AKT, TUB, H3: fractioning and
Additional file 1: Figure S1C). (E) Induced interaction of pERK and BMI1 in r
controls: PRC1 proteins CBX4 and PHC1; PCR1 interaction confirmed by BM
cDNA.have revealed changes in Polycomb/chromatin distribu-
tion and transcriptional reprogramming during lineage
commitment and differentiation [8-10]. As M/SAPKs and
MKs also play important roles in differentiation, develop-
ment and cell proliferation, the physical association of
PRC1 and MK3 suggests a functionally relevant connec-
tion. We have previously established that PRC1/chromatin
dissociation correlates with their phosphorylation status
during cell cycle progression [11]. Subsequently, we
showed that acute mitogenic and stress signaling also
results in PRC1/chromatin dissociation [5]. The molecular
mechanisms that underlie this dynamic relocation of
PRC1 and the exact role of MK3 in signaling to chromatin
remained unknown. We here hypothesized that M/SAPK-
MK signaling imposes a molecular mechanism by which
cells regulate PRC1/chromatin association and PRC1 tar-
get gene expression in response to environmental cues.
We used the previously identified PRC1 target gene ATF3
to study PRC1-mediated transcriptional regulation [12].
ATF3 is an immediate-early response gene (IEG) [13];
relevantly, ERK and MK have been implicated in IEGPRC1 target gene ATF3 expression (mRNA) in mitogen-stimulated
SD. (C) H3S28ph and BMI1 staining in starved or mitogen-stimulated
ution in starved and stimulated U2-OS cells; nuclear soluble and
rrespond to approximately three to four cytoplasmic equivalents.
direct quantitative comparison (corresponding sections are shown
loading controls (quantification chromatin-bound BMI1: compare
esponse to mitogens (stim) or selenite (stress) in U2-OS cells; loading
I1/CBX4 co-immunoprecipitation (co-IP); +/−: transfected BMI1-2Py
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tion represents a suitable model to study the biological
relevance of ERK/MK3/PRC1 signaling. Our current data
establish that ATF3 expression is dynamically controlled
by MAPK/MK/PRC1, and identify important players in an
epigenetic switch-module in response to changes in the
cellular microenvironment.
Results and Discussion
M/SAPK signaling controls PRC1 target gene transcription
To determine how M/SAPKs are implicated in Polycomb-
mediated repression, transcription of the PRC1 target
gene ATF3 was measured in the presence or absence of
kinase inhibitors. All cells were serum starved (G0/G1-ar-
rest) prior to stimulation throughout this study, to avoid
interference by late S/G2-associated PRC1/chromatin dis-
sociation [11]. ERK, P38 and jun N-terminal kinase (JNK)
are all phosphorylated in response to mitogenic stimula-
tion (Additional file 1: Figure S1A). Consistent with
immediate-early response kinetics, ATF3 mRNA levels
rapidly increase and peak at 60 minutes after stimulation
(Figure 1A). P38 inhibition (p38i) and MEK/ERK inhib-
ition (MEKi) both substantially and reproducibly reduce
ATF3 induction; the effect of ERK inhibition is consist-
ently stronger than p38i (± 3- to 4-fold versus± 1.5- to 2-
fold, respectively); combining both inhibitors blocks ATF3
expression completely; JNK inhibition (JNKi) slightly
enhances ATF3 induction (Figure 1B). Various PRC1 pro-
teins cluster to pericentromeric heterochromatin-
associated Polycomb Group nuclear bodies (PcG-NB) in
several cancer cell lines [11,15,16]. Using PcG-NB/ chro-
matin dissociation in U2-OS cells as a read-out for PRC1/
chromatin binding [5,11], we find that PcG-NB/chromatin
dissociation correlates well with increased histone H3
phosphorylation at Ser28 (H3S28ph) in mitogen-
stimulated control cells, in concordance with previous
observations [5], and that combined MEKi/p38i blocks
both events (Figure 1C). H3S28 is phosphorylated by nu-
merous triggers and MAPKAPK-family kinases, including
RSKs and MSKs [17,18]. Of note, immediate-early re-
sponse genes (IEG) are controlled by MKs and local
H3S28 phosphorylation [14,19]. In the context of mito-
genic stimulation, we find that P38i alone can block
H3S28ph and chromatin dissociation of the PRC1 protein
BMI1, whereas BMI1/chromatin binding is largely
retained when ERK signaling is interrupted (MEKi), with-
out affecting H3S28ph (Additional file 1: Figure S1B).
These results support the notion that P38 targets H3S28
and that ERK signaling may target PRC1/chromatin asso-
ciation, and possibly PRC1 protein function and/or inter-
action. To examine the effect of mitogenic stimulation on
subnuclear distribution of PRC1 proteins (in the presence
or absence of kinase inhibitors), cells were differentially
extracted to yield cytoplasmic, soluble nuclear andchromatin-bound fractions. We previously found that the
PRC1 protein PHC1 undergoes a global chromatin redis-
tribution in response to cell stress in contrast to some
other PRC1 members [5]; as such, determination of total
(that is, PcG-NB and global) PRC1 protein/chromatin as-
sociation is pivotal. Of note: mitogenic stimulation differ-
entially affects global PHC1/, CBX4/ (both increased) and
BMI1/chromatin association (decreased), suggesting dif-
ferential regulation of PRC1 members by M/SAPKs. Con-
sistent with this, single inhibitor treatment (p38i or MEKi)
clearly affects chromatin association of PRC1 proteins in
distinct ways (Figure 1D). Combined inhibitor treatment
of stimulated cells shows that more BMI1 remains chro-
matin-associated, consistent with the immunofluorescence
(IF) analysis (Figure 1D,C, Additional file 1: Figure S1C);
also CBX4/ and PHC1/chromatin binding are increased
under p38i/MEKi conditions. The fluctuation of CBX4
levels suggests a direct involvement of phosphorylation in
relation to chromatin association. Besides differential
phosphoregulation of PRC1 proteins by M/SAPKs, the
above findings predicted an interaction between MAPK
and PRC1, downstream of mitogenic signaling. Indeed,
co-immunoprecipitation analyses confirm a signaling-
induced interaction between pERK and PRC1 complexes
(Figure 1E). The PRC1/pERK interaction is counteracted
by P38 signaling, as more pERK co-precipitates in a
PRC1-directed IP in p38i cells (Additional file 1: Figure
S1D, compare Figure 1D), in support of cross-talk be-
tween kinases at multiple levels. The combined data dem-
onstrate that mitogenic signaling, via both activated P38
and ERK, converges at the level of PRC1/chromatin regu-
lation and target-gene activation, and establish a relevant
functional interaction between these signal transducers
and PRC1.
Transcription correlates with PRC1 dissociation, not loss
of H3K27me3
We next studied changes in PRC1 (CBX8, PHC1) chro-
matin occupation and H3K27me3 marks at established
PRC1 target genes [12]. CBX8 and PHC1 show distinct
chromatin-occupation profiles: whereas CBX8 is exclu-
sively enriched at PRC1 target loci and is released upon
serum stimulation at most targets, PHC1 appears present
also at non-target genes and shows opposing dissociation
dynamics at targets (decreased; ATF3; HOXA11) and non-
targets (increased; p15 exon1, CCNA2, p14ARF exon1)
upon stimulation (Figure 2A). The observed changes in
PHC1 occupation are consistent with enhanced chromatin
association in response to mitogens (compare Figure 1D).
We find a clear correlation between simultaneous chro-
matin dissociation of CBX8 and PHC1, and activation of
expression at the ATF3 locus (Figure 2A, Additional file 2:
Figure S2A). As CBX8 levels remain unaltered throughout
the duration of the experiment, this does not account for
Figure 2 PRC1/chromatin dissociation, not loss of H3K27me3,
correlates with transcription. (A,B) Chromatin immuno-
precipitation (ChIP) analysis of PRC1 protein binding, histone
H3K27me3 (A) and H3S28ph marking (B) at known PRC1 target and
non-target loci in G1-arrested (starved) and mitogen-stimulated TIG3
cells. ChIP antisera are indicated in the figures (ChIP antibodies (aB)).
(Statistical significance: *P< 0.05, **P< 0.01; t-test.
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2: Figure S2B). In contrast to CBX8, PHC1 increases at all
non-induced loci (Figure 2A, Additional file 2: Figure
S2A). The contrasting chromatin-binding dynamics of
CBX8 and PHC1 in response to signaling are in good
agreement with our previous observation that PHC1/
chromatin binding appears to increase globally in the con-
text of cell cycle progression or cell stress, whereas detec-
tion of other PRC1 members in PcG-NB (like BMI1,
CBX4 and RNF2) is reduced [5,11]. Of note, PHC/PRC1-
core complex association was reported to be relatively
weak [20]. In addition, purified PHC1 is known to reside
in non-PRC complexes [21]. Combined, these results indi-
cate that PHC1 occupation occurs without the need for
simultaneous CBX8 binding, and further supports the no-
tion of differential regulation of PRC1-complex members.The observation that both CBX8 and PHC1 removal cor-
relate with ATF3 expression, whereas PHC1 is retained/
increased at the CDKN2A/INK4A locus (Figure 2A, Add-
itional file 2: Figure S2A) suggests that multiple/all PRC1-
core complex members may need to dissociate at crucial
regulatory regions to allow active transcription. It is con-
ceivable that signaling through M(S)APK/MK3/PRC1
changes the local epigenomic state from a repressed/
poised state [12,22,23] to a ‘de-repressed’ and eventually
fully transcriptionally active state through progressive loss
of PRC1 members.
Consistent with a global mitogen-induced increase of
H3S28ph, ChIP analysis shows increased H3S28ph en-
richment at PRC1 targets as well as non-targets; this epi-
genetic change occurs independent of transcriptional
induction (Figure 2B, Additional file 2: Figure S2A). Re-
markably, the unaltered H3K27me3 occupation at the
ATF3 promoter suggests that transcriptional activation
of PRC1 target genes occurs without concomitant loss of
H3K27me3 (Figure 2A). Thus, although PcG-NB/chro-
matin dissociation and H3S28ph correlate well [5,24,25],
H3S28ph by itself does not determine transcriptional
status. In addition, our findings argue that local main-
tenance of H3K27me3 does not obstruct transcriptional
reactivation of PCR1 targets. The recently reported pres-
ence of H3K27me3 marks on active promoters supports
this notion [26]. Whether or not the H3K27me3 mark
needs to be removed at reactivated genes remains
contradictory at this point [24-26], and may, besides on
models and tools used, depend on the subgenic location
of epigenetic modifications (possibly in conjunction with
other modifications). Consistent with this idea, repres-
sive H3K27me3 marking correlates best with transcrip-
tion at loci that display ‘blanketing’-type H3K27me3
enrichment, that is, gene body-wide (downstream of the
transcription start site (TSS)) [26]. It is conceivable that
H3K27me3 promoter marking defines a specific class of
response factors, which are dynamically controlled by
rapid removal of PRC1 complexes. Thus far, our
H3S28ph analyses suggest that H3S28ph, like CBX8 dis-
sociation, is a global event; despite being essential for
PRC1 target gene activation, it is clearly not the sole de-
termining factor and as such is unlikely to specify regu-
lation only at PRC1 target genes. Co-occurrence of
methylphosphoryl modifications on adjacent histone
lysines and serines was proposed to act as a binary epi-
genetic switch mechanism, by affecting chromobox-
domain binding to histone-trimethyl marks [24,27-29];
Interestingly, also EZH2/chromatin dissociation at muscle-
specific promoters during myogenesis appears driven by
local H3K27 methyl/H3S28 phosphoryl modification
[30,31]. The simultaneous detection of local H3S10ph and
HP1 binding, however, seemingly challenges the strictness
of the methylphosphoryl switch concept [32]. Irrespective
Figure 3 MK3 is a negative regulator of ERK. (A,D) mRNA expression of PRC1 target gene ATF3 as a function of kinase inhibition (A) or MK3OE
(D) in TIG3 cells. (B,C, E, F) (p)ERK (B), (p)P38 (C), H3S28ph (E) and (p)MEK (F) levels in starved and stimulated U2-OS cells in relation to MK
function; t (min): time post-stimulation in minutes; *: loading controls for corresponding panels; t+: longer exposure. Samples corresponding to
control and experiment (MK3OE or MKi) were always loaded on the same gel to enable direct quantitative analysis (corresponding sections are
shown separately; representative experiment shown; quantification pERK profiles: compare Additional file 3: Figure S3B). (G) Mitogen-induced
DUSP2 and DUSP5-mRNA in control, MK3OE and MKi TIG3 cells.
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etic analyses suggest PRC1 target gene activation does not
require loss of H3K27me3 and point to chromatin dissoci-
ation of multiple PRC1 proteins as an important event in
transcription initiation.
MK3 negatively regulates ERK signaling
To determine the role of MK in PRC1 target gene regu-
lation, we next studied the effects of MK inhibition or
MK protein level modulation on ATF3 gene expression
in TIG3 and U2-OS cells. MK inhibition (MKi) releases
basal repression of ATF3 in starved MKi cells and allows
for more robust ATF3 mRNA induction; in contrast,
treatment with MEKi or p38i, both suppress transcrip-
tion (Figure 3A, Additional file 3: Figure S3A). Of note:
MKi does not show an added effect on ATF3 mRNA
synthesis in combination with other single or multiple
kinase inhibitors, suggesting that MKs exert their effectupstream of ERK and P38 signaling (Figure 3A). Thus,
our data suggests a negative regulatory role for MKs in
mitogenic signaling through MEK/ERK. In good agree-
ment with this data, MK-deficient cells (by MKi or
shRNA-mediated knockdown (shMK)) display sustained
ERK1/2:T202/T204 phosphorylation (pERK; up to 90 to
120 minutes, compared to control cells) upon stimula-
tion (Figure 3B, Additional file 3: Figure S3B,C). Con-
versely, MK3 overexpression (MK3OE) reduces both
basal and induced ATF3 transcription, and, in combin-
ation with MEKi/p38i, further represses expression
(Figure 3D). As predicted, MK3OE delays ERK phos-
phorylation, consistent with an inhibitory action of MK3
on ERK activity and reduced target-gene induction
(Figure 3B,D, Additional file 3: Figure S3B). MK2 was re-
cently found to stabilize P38 in a kinase domain-
independent manner, that is, physical association of
MK2 to P38 controls P38 stability [33]. Analogous with
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versus reduced P38 levels in shMK cells; relevantly, P38
levels remain unaltered in MKi cells (Figure 3C,
Additional file 3: Figure S3D). Contrary to pERK, P38:
T180/T182 phosphorylation (pP38) is reduced in
MK3OE cells as well as in shMK and MKi cells. Also
JNK:T183/T185 phosphorylation (pJNK) is reduced by
shMK, whereas MK3OE correlated with enhanced JNK
levels (Additional file 3: Figure S3E,F). Although the full
extent of factors and mechanisms controlling M/SAPK
phosphorylation is not clear at this point, these findings
are in keeping with multiple complex regulatory cross-
interactions between MKs and M/SAPKs [3,34].
Consistent with our IF analyses (compare Figure 1C,
Additional file 1: Figure S1B), H3S28 shows rapid and
transitory phosphorylation kinetics in response to mito-
gens (Figure 3E). Relevantly, global H3S28ph is
increased and sustained in MKi cells, whereas it is
blunted in MK3OE cells (Figure 3E) in line with altered
PRC1 target gene expression under these respective con-
ditions (compare Figure 3A,D). This data demonstrates
that H3S28 phosphorylation kinetics respond to MK3
activity, and support a regulatory role for MK3 in epi-
genetic modulation of cell responses to environmental
stimuli.
To gain further insight into the molecular mechanisms
by which MK3 controls M/SAPK activity, we studied
MEK, an ERK effector kinase. MEKpT292 and MEKpS298
were examined, as these two phosphoresidues are part of
a mechanism that controls MEK activity [35]. Like pERK,
MEKpT292 is also sustained in MK-deficient cells, sug-
gesting that MK3 controls phosphatase activity directed
toward upstream kinases (Figure 3F). Dual-specificity
phosphatases (DUSPs) play important roles in feedback
loops on phosphorylation cascades [36]. DUSP2 and
DUSP5 induction meet the criteria of being dependent on
mitogenic signaling and on MK, as MK3OE and MKi, en-
hance and decrease DUSP mRNA induction, respectively
(Figure 3G). To validate the involvement of DUSPs in the
negative regulatory network involving MK3, we used in-
duction of EGR1 as a read-out for mitogen-induced ERK
activity [37]. MKi cells display a stronger EGR1 induction
(Additional file 4: Figure S4A), consistent with loss of
negative regulation via ERK. To validate a role for phos-
phatase activity in regulation of the ERK/EGR1 response,
cells were pretreated with orthovanadate, a generic DUSPs
inhibitor (DUSPi). Enhanced EGR1 expression in the pres-
ence of DUSPi resembles that observed in MKi cells and
supports a negative regulatory role for DUSPs in the
MK3/ERK/EGR1 response (Additional file 4: Figure S4B);
in line with reduced negative feedback in DUSPi cells,
both pERK and pP38 are increased in response to mito-
genic stimulation. Relevantly, also signaling-induced
H3S28ph levels are enhanced significantly in the presenceof DUSPi, in agreement with a functional role for DUSPs
in epigenetic regulation (Additional file 4: Figure S4B).
Relevantly, the reduced ERK phosphorylation by MK3OE
is partially reversed by DUSP inhibition, suggesting that
DUSP activity acts as part of a relay system in the regula-
tory feedback of MK3 to MEK/ERK (Additional file 4:
Figure S4C). Combined, the above findings support a
negative regulatory role for MKs in MEK/ERK signaling,
at least in part, via induction and/or activation of
phosphatases.
To obtain independent proof for the functional relation-
ship between MKs and M/SAPKs, we examined kinase
interactions in Drosophila melanogaster. We first repro-
duced a signaling-induced interaction between Ph-p
(PHC1/2 ortholog) and dMK2 (the only MK ortholog in
D. mel) in cultured insect cells (Additional file 5: Figure
S5A). We next exploited Drosophila wing vein patterning
to probe for M/SAPK-MK interaction in vivo. Wing vein
formation in the fruit fly is dependent on MAPKs [38-40].
As expected, gain-of-function (GOF) lines for dERK/rolled
(sd::Gal4>UAS::rolled; D.mel ERK ortholog) show ectopic
wing veins during wing imaginal disc development
(Figure 4A,B). We here report that flies overexpressing D-
p38b (sd::Gal4>UAS::D-p38b; one of the D.mel P38
orthologs) also display enhanced ectopic vein formation
(Figure 4A,B). Hence the ectopic vein phenotype can be
used to gauge the effects of MK loss-of-function (LOF) on
ERK/P38 pathway activity. To determine the effect of
dMK2 on dERK and D-p38b, we crossed a transgenic
RNAi-mediated dMK2-knockdown line (v3171) to dERK-
and D-p38b-GOF lines (see: Methods section, Additional
file 5: Figure S5B). dMK2-LOF enhances the dERK-GOF
ectopic vein phenotype (Figure 4A,B). In contrast, dMK2-
LOF suppresses the ectopic vein phenotype induced by D-
p38b-GOF (Figure 4A,B). Importantly, this data is fully
congruent with our in vitro findings in mammalian cells
and supports the existence of a complex genetic network
between MAPKs, SAPKs and MKs. In conclusion, our
in vivo experiments substantiate a negative regulatory role
of dMK2 on dERK-signaling in wing vein development.
Conclusions
In summary, we here identify and carefully characterize
a number of actors in PRC1-dependent gene regulation.
Signaling through P38 has direct implications for local
chromatin modulation (that is, H3S28 phosphorylation).
We propose that ERK/PRC1/MK3 acts as a molecular
dimmer switch that enables rapid and reversible tran-
scriptional activation of ATF3. This mechanism defines
negative feedback on Polycomb-mediated repression as
an integral process in the regulation of appropriate cel-
lular responses to environmental changes (Figure 5).
Whereas part of the responses appears global, like
H3S28 phosphorylation and CBX dissociation, the
Figure 4 Negative feedback by dMK2 on dERK/rolled in ectopic wing vein development. (A, B) Representative ectopic vein patterns (black
arrows) in control (a) and transgenic lines (b,c); percentages of flies with ectopic wing veins in different genetic contexts (indicated below graph;
B); #: sd::Gal4 driver-induced ectopic veins nearby vein 2 (l2; white arrow head compare A), were not scored; *: significantly different from
corresponding genotype without dMK2-LOF (z-test; P< 0.001).
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targeting of pERK and provides specific local regulation.
PRC-complex members are emerging as proteins har-
boring many different functions and binding partners
[7]. We recently categorized ± 120 known phosphoryl-
ation sites on a limited number of PRC proteins; many
of these sites are predicted M/SAPK target sites and are
likely to cooperate in gene regulation [41-44]. Although
some phosphosites have been linked to PRC protein
function [45-49], the biological relevance of the vast ma-
jority of these phosphorylation events is currently un-
known. Our findings pave the way for detailed mutational
analysis of the functional consequences of post-
translational modification of Polycomb proteins. The find-
ings presented herein provide novel insight into differen-
tial regulation of PRC1 members in response to signaling
and add to the growing recognition that PRC1-mediated
repression is a highly dynamic process.
Methods
Cell culture, viral infections
Human U2-OS osteosarcoma cells and TIG3 primary
human fibroblasts expressing the murine ecotropicreceptor were kindly provided by Dr. D. Shvarts (Utrecht
Medical Center, Utrecht, The Netherlands) and Dr. D.
Peeper (Netherlands Cancer Institute (NKI), Amsterdam,
The Netherlands), respectively. Expression vectors encod-
ing the murine ecotropic receptor were a courtesy of Dr. R.
Bernards (NKI, Amsterdam, The Netherlands). All human
cell lines were cultured under standard conditions in
DMEM containing 10% fetal calf serum (FCS). Retroviral
expression vectors were used to maximize percentages of
expressing cells and to minimize integration effects. Pro-
duction of infectious viral particles was carried out as
described previously [50]. Briefly, ecotropic retroviral super-
natants were produced by transfection of producer cells
using calcium-phosphate co-precipitation. Forty to forty-
eight hours post-transfection, the supernatants were har-
vested, filtered and stored at −80°C until further use. Viral
titers were sufficiently high to achieve near 100% infection.
Cells were transduced with retrovirus in the presence of
4 μg/ml polybrene (Sigma-Aldrich, St. Louis, MO, USA) at
around 25% confluency for six to eight hours and then
allowed to recover for forty-eight hours on fresh medium
before selection pressure was applied. Transduced cells
were grown for± 1 week on 1 to 4 μg/ml puromycin
Figure 5 Model for MAPK/MK regulation of PRC1 target genes. The PRC1/MK/ERK module represents a molecular switch mechanism: fine-tuning
of converging P38 and ERK signals at the chromatin level triggers a potential methylphosphoryl switching module and a signaling-dependent disruption of
the PRC1/chromatin association that permits gene activation. Transient H3S28ph, but not removal of H3K27me3, accompanies gene expression.
Concomitant MK activation initiates DUSP-dependent negative regulatory feedback on MEK/ERK (and possibly also on H3S28ph; dashed lines reflect
potential functional relationships).
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constructs was verified by immunoblotting.
Cells were serum-starved at 0.1% FCS for 48 hours.
Mitogenic stimulation was achieved by supplementing
15% FCS/100 ng/ml tetradecanoylphorbol acetate (TPA;
Sigma) for 45 minutes or as indicated. Cells were pre-
treated with kinase inhibitors: 30 minutes 10 μM MEK
inhibitor (U0126; Promega, Madison, WI, USA), 30 min-
utes 10 μM MK inhibitor (MK2a Inhibitor; Calbiochem/
Merck, Darmstadt, Germany), 30 minutes 20 μM p38 in-
hibitor (SB202190; Calbiochem), 30 minutes 25 μM JNK
inhibitor (SP600125; Biomol, Plymouth Meeting, PA,
USA), 30 minutes 85 μM etoposide (ETP; Calbiochem).
MK2a was confirmed to inhibit MK3 (data not shown).
Cells were preincubated with sodium orthovanadate for
30 minutes prior to mitogenic stimulation at indicated
concentration; control cells were incubated with solvent.
Sodium selenite (Sigma) -treated cells (90 minutes
0.2 mM) were used as a positive control. Drosophila S2
cells were cultured at 25°C in Schneider medium with10% FCS. The day before transfection, 5.106 cells were
transferred in medium with 0.1% FCS. For transfection,
2 μg of plasmid DNA were mixed with Effecten™ trans-
fection reagent (Qiagen, Hilden, Germany) according to
manufacturer’s instructions (1/10 DNA-Effecten™ ratio).
Forty-eight hours later, cells were either untreated, sti-
mulated with 10% FCS/100 ng/ml TPA or 0.5 mM so-
dium meta-arsenite for two hours at 25°C. For
immunoprecipitation (IP) experiments, plasmids Act::
Myc-Ph and Act::EGFP-MAPKAP were co-transfected
into S2 Drosophila cells grown in 0.1% FCS. IPs were
performed as described (Mouchel-Vielh et al., 2011); IP
antibodies are listed in Additional file 6: Table S1.Expression constructs
Retroviral vectors (pBMN-LZRS.ires.GFP, pBMN-LZRS.
ires.NEO) expressing murine BMI1-2Py or GST-MK3
have been described elsewhere [5,11]. Retroviral systems
were used as published [51,52]. RNA-interfering MK3
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targeting sequences: Additional file 7: Table S2.
The dMK2 cDNA was amplified from clone SD05481
(Drosophila Genomics Resource Center; for oligonucleo-
tides: see Additional file 7: Table S2). The resulting
amplicon was introduced into pENTR/D-TOPO™ (Invi-
trogen, Carlsbad, CA, USA), then transferred through
LR-recombination into T. Murphy’s vectors pAWG
(https://dgrc.cgb.indiana.edu/vectors). Similarly, a cDNA
corresponding to the C-terminal part of Drosophila
Polyhomeotic-proximal gene (Ph or Ph-p) was amplified,
introduced in pENTR/D-TOPO™, and subsequently
transferred in pAMW (for oligonucleotides: see
Additional file 7: Table S2) [54]. Ph sequences in the
Act::myc-Ph construct endoded the 346 C-terminal
amino acids of the Ph-proximal protein (GenPept quali-
fiers: NP_476871.2 GI:24639272) and included the SAM
domain through which MK3 and PHC1/2 interact [5].
Chromatin immunoprecipitation (ChIP) assays
ChIPs on primary human fibroblasts were performed
and analyzed essentially as described [12]. Cells were
fixed for 10 minutes in 1% formaldehyde/phosphate buf-
fered saline (PBS) and stopped by 5 minutes incubation
in glycine (final concentration: 0.125 M). Fixed cells
were washed twice with PBS and harvested in SDS buf-
fer (50 mM Tris at pH 8.1, 100 mM NaCl, 0.5% SDS,
and 5 mM EDTA), supplemented with protease inhibi-
tors (aprotinin, antipain and leupeptin all at 5 μg/ml and
1 mM PMSF). Cells were pelleted by centrifugation, and
suspended in IP buffer (100 mM Tris at pH 8.6,
100 mM NaCl, 0.3% SDS, 1.7% Triton X-100, and 5 mM
EDTA), containing protease inhibitors. Cells were dis-
rupted by sonication, yielding genomic DNA fragments
with a bulk size of 200 to 500 bp. For each IP, 1 ml of
lysate was precleared by adding 35 μl of blocked protein
A beads (Protein A-Sepharose/CL-4B (GE Healthcare,
Piscataway, NJ, USA); 0.5 mg/ml fatty acid-free BSA
(Sigma); and 0.2 mg/ml herring sperm DNA in TE buf-
fer), followed by centrifugation. 10 μl aliquots of pre-
cleared suspension were put aside as input DNA and
kept at 4°C. Samples were immunoprecipitated overnight
at 4°C. HA antiserum was used as negative control. Im-
mune complexes were recovered by adding 40 μl of
blocked protein A or G beads (GE Healthcare) and incu-
bated for 4 hours at 4°C. Beads were washed three times
in 1 ml of mixed micelle buffer (20 mM Tris at pH 8.1,
150 mM NaCl, 0.2% SDS, 1% Triton X-100, 5 mM
EDTA, and 5%w/v sucrose), twice in 1 ml of buffer 500
(50 mM HEPES at pH 7.5, 1% Triton X-100, 1 mM
EDTA, and 0.1%w/v sodium deoxycholate), twice in
1 ml of LiCl detergent wash buffer (10 mM Tris at pH
8.0, 1 mM EDTA, 0.5% sodium deoxycholate, 0.5% NP-
40, and 250 mM LiCl), and once in 1 ml TE buffer.Immune complexes were eluted from beads in 250 μl
elution buffer (1% SDS and 0.1 M NaHCO3) for 2 hours
at 65°C (continuous shaking at 1000 rpm), and after cen-
trifugation, supernatants were collected. 250 μl elution
buffer was added to input DNA samples and these were
processed in parallel with eluted samples. Cross-links
were reversed overnight at 65°C, followed by 2 hours di-
gestion with RNase A at 37°C and 2 hours proteinase K
(0.2 μg/μl) at 55°C. DNA fragments were recovered
using QIAquick PCR purification columns, according to
manufacturer’s instructions (Qiagen, Hilden, Germany).
Samples were eluted in 75 μl EB buffer and then diluted
1:5 in TE buffer. Immunoprecipitated DNA was quanti-
fied by real-time PCR (for ChIP antisera, primers: see
Additional file 6: Tables S1, Additional file 7: Table S2).
Each experiment was performed in triplicate. Results of
one representative experiment are shown.
RNA isolation, cDNA synthesis, real-time (RT) PCR analysis
For RT-PCR analysis, total RNA was isolated using Tri
Reagent (Sigma) according to the manufacturer’s proto-
col. Quantity and quality of the RNA were determined
by 260/280 nm and 260/230 nm absorbance measure-
ments, respectively, using the Nanodrop (Witec AG,
Luzern, Switzerland). Total RNA (1 μg) for each sample/
replicate was converted into first strand cDNA using the
iScript™ cDNA synthesis kit (Bio-Rad, Hercules, CA,
USA) according to the manufacturer’s instructions. Gene
expression was determined by RT-PCR using the
MyiQ™ thermal cycler (Bio-Rad) in combination with
the IQ5 version 2.1 software (Bio-Rad). RT-PCR was
performed on 25 ng of cDNA using the qPCR iQ™ Cus-
tom SYBR™ Green Supermix with fluorescein (Bio-Rad)
and 300nM primer in 96-well plates (Bio-Rad). For each
primer pair a standard curve was generated with a serial
dilution of a cDNA pool. RT-PCR data was analyzed
according to the relative standard curve method. All
values were normalized to either beta-Actin (Additional
file 2: Figure S2) or cyclophillin A (Figures 1,3, Add-
itional file 1: Figure S1, Additional file 3: Figure S3). The
control condition is used as a reference. Primer sets for
the selected genes were developed with Primer Express
version 2.0 (Applied Biosystems, Foster City, CA, USA)
using default settings (Additional file 7: Table S2).
Immunofluorescence
Cells were grown on 6- or 12-well culture plates
(Greiner Bio-One, Alphen aan de Rijn, The Netherlands)
to ± 60 to 80% confluency, pretreated when applicable,
washed twice with PBS, and either fixed for 15 minutes
in 2% formaldehyde/PBS at room temperature (RT) fol-
lowed by a 15 minutes incubation in chilled 100%
methanol (MetOH) at −20°C, or directly fixed in 100%
MetOH for 15 minutes at −20°C. Fixed plates were
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three times with PBS and used for immunocytochem-
istry (IC). For detection of PRC1 proteins and histone
modifications, cells were first permeabilized for 10 min-
utes at RT in 0.2% Triton X-100 (TrX) in PBS. After ex-
tensive washing in PBS/0.02% TrX, cells were incubated
with primary antibody (Additional file 6: Table S1) for
1.5 to 2.5 hours in a prewarmed humidified chamber at
37°C, washed five times in PBS/0.02% TrX and incu-
bated with fluorescently labeled secondary antibody for
60 minutes at 37°C. 4′-6-diamidino-2-phenylindole
(DAPI) was co-incubated with secondary conjugated
antibodies to counterstain cell nuclei. Plates were
washed in PBS/0.02% TrX, rinsed in PBS and subse-
quently dehydrated: 1 minute in 70% EtOH, two times
1 minute in 100% EtOH and air-dried. Cells were
mounted in Vectashield (Vector Laboratories, Inc. Bur-
lingame, CA, USA), analyzed using a Nikon TE200
Eclipse fluorescence microscope and photographed
using a Nikon DXM1200 digital camera in combination
with NIS-Elements 3.0 imaging software. All antibodies
were diluted in blocking buffer (1% BSA, 5% FCS, 5%
normal goat serum (NGS), in PBS/0.02% TrX). Second-
ary antisera used were goat-anti-mouse Texas Red™
(TXRD; 1:100; Southern Biotech, Birmingham, LA,
USA) and goat anti-rabbit fluorescein isothiocyanate
(FITC; 1:100; Southern Biotech), to detect monoclonal
and polyclonal primary antibodies respectively.Protein isolation, differential extraction,
immunoprecipitation (IP), immunoblotting (IB)
Protein extraction and immunoblotting (IB) were
performed and analyzed as described previously with
minor adjustments [2,5]. For extraction, cells were
washed twice with cold PBS and lysed in RIPA buf-
fer (50 mM Tris at pH 8.0, 150 mM NaCl, 0.1%
SDS, 5 mM EDTA, 0.5%w/v sodium deoxycholate,
and 1% NP-40) supplemented with protease and
phosphatase inhibitors (5 mM benzamidine, 5 μg/ml
antipain, 5 μg/ml leupeptin, 5 μg/μL aprotinin, 1 mM so-
dium orthovanadate, 10 mM sodium fluoride, 10 mM
pyrophosphate, 10 mM ß-glycerophosphate, 0.5 mM
DTT, and 1 mM PMSF). Lysates were subjected to two
freeze-thaw cycles in liquid nitrogen, followed by sonic-
ation on ice with a probe sonicator (Soniprep 150; MSE,
London, UK) for 12 cycli (1 sec ON, 1 sec OFF) with amp-
litude 5. After 10 minutes centrifugation at 13200 rpm
(4°C; Eppendorf centrifuge), the supernatant was trans-
ferred to a fresh tube and protein concentration was
determined using a BCA protein assay kit (Pierce/Thermo
Fisher Scientific, Rockford, IL, USA) according to the
manufacturer’s protocols on a Benchmark 550 microplate
reader (Bio-Rad).For differential extraction, cells were washed two
times with cold PBS and scraped in lysis buffer (Tris
HCl at pH 7.5, 150 mM NaCl, 0.5% Triton X-100,
1 mM EDTA; supplemented with inhibitors). After
30 minutes incubation on ice, nuclei are collected in
the pellet by centrifugation (8000 rpm; 4°C) the
supernatant is the cytoplasmic fraction. Nuclei are
washed in lysis buffer and suspended in ELB buffer
and incubated on ice for 10 minutes. Nuclear soluble
(supernatant) and chromatin-bound fractions (pellet)
are separated by centrifugation (13200 rpm; 4°C).
After an additional wash in ELB buffer, the pellets
were suspended in ELB buffer and sonicated.
For IP, cells were either cross-linked followed by cell
lysis, or cells were lysed directly in ELB buffer (50 mM
HEPES at pH 7.0, 250 mM NaCl, 5 mM EDTA, and
0.1% NP-40) supplemented with 5 mM benzamidine,
5 μg/ml antipain, 5 μg/ml leupeptin, 5 μg/ml aprotinin,
1 mM sodium vanadate, 10 mM sodium fluoride,
10 mM pyrophosphate, 10 mM ß-glycerophosphate,
0.5 mM DTT, and 1 mM PMSF. For cross-linking, cells
were incubated in 1% formaldehyde (in PBS) for 10 min-
utes at RT, fixation was stopped by addition of 2 M gly-
cin to a final concentration of 0.125 M. After 5 minutes
incubation, cells were washed twice in cold PBS and
lysed in ELB buffer. IP was carried out as described
[11,15]. Briefly, extracts were sonicated on ice, centri-
fuged for 10 minutes at 4°C at 13200 rpm and superna-
tants were transferred to a precooled tube; 10% of the
supernatant was taken as input and stored at −80°C. Ap-
propriate amount of antiserum (Additional file 6: Table
S1) was added and tubes were rotated for 1 hour at 4°C
on a spinning wheel. To precipitate immune complexes,
washed protein G beads (Protein G Sepharose/4 Fast
Flow; GE Healthcare) were added to the extracts and
rotated for 3 to 4 hours at 4°C, followed by 3 minutes
centrifugation at 3000 rpm at 4°C. Supernatant was col-
lected as depleted fraction and stored at −80°C. Beads
were washed four times in ELB buffer (with supple-
ments) and stored dry at −80°C until IB analysis.
For IB, equal protein amounts were boiled in sam-
ple buffer for 5 minutes and loaded on 9 to 15%
polyacrylamide gels. Following separation by SDS-
PAGE, proteins were transferred onto polyvinylidene
fluoride (PVDF) membranes (GE Healthcare). Pon-
ceau S (Sigma) staining was used to check protein
transfer. PVDF membranes were blocked with 3.4%
non-fat dry milk (Protifar; Nutricia, Zoetermeer, the
Netherlands) in PBS containing 0.1% Tween 20 (pH
7.5) for 1 hour at RT, followed by an overnight incu-
bation at 4°C with the primary antibody (Additional
file 6: Table S1; anti-CBX4 [55]). After extensive
washing with PBS/0.2% Tween 20, membranes were
probed with corresponding horseradish peroxidase-
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goat anti-rat (7077; 1:2,000; Cell Signaling, Danvers,
MA, USA), rat anti-mouse (P0260; 1:5,000; DAKO,
Glostrup, Denmark) and donkey anti-rabbit (711035-
152; 1:15,000; Jackson Lab, Bar Harbor, ME, USA),
to detect monoclonal rat, monoclonal mouse and
rabbit polyclonal primary antibodies respectively. Sig-
nals were detected on autoradiograms using
enhanced chemoluminescence (ECL; Pierce). Inten-
sity of the bands was quantified with Quantity One
software (Bio-Rad).
Drosophila lines
Drosophila melanogaster stocks and crosses were kept
on standard media at 25°C. For crosses, five females
were mated with five males; they were transferred each
48 hours in new tubes. The w1118 line was used as con-
trol line. The UAS::rolled line was a gift from Dr. K.
Moses (University of Cambridge, Cambridge, UK); the
UAS::D-p38b was a gift from Dr. JM Gibert (University
of Geneva, Geneva, Switzerland); UAS::rolled and UAS::
D-p38b allow dERK and D-p38b overexpression, respect-
ively [38,56]. The v3171 line (w1118; MAPk-Ak2GD1597)
that downregulates dMK2 by RNA interference, was
purchased from the Vienna Drosophila RNAi Center
(VDRC) [57]; it does not present any known off-target
effects. Downregulation of dMK2 in third instar larvae
was verified by real-time (RT) PCR using primers
located outside the v3171 repeats (Additional file 5:
Figure S5B) as described [41]. Results were normalized
against rp49 or Spt6 (Additional file 7: Table S2). Trans-
gene overexpression was achieved using the wing-
specific Gal4 transgenic driver scalloped sd29.1 (called
sd::Gal4; BL-8609 line; Bloomington Drosophila Stock
Center (BDSC), Bloomington, IN, USA)). All the trans-
genic lines display Gal4-independent mini-white expres-
sion that allows tracing of transgene transmission.
dMK2-LOF and hMK3-GOF transgenic flies were also
crossed to mutant Polycomb lines to study a potential
interaction of MK and PcG in vivo. Neither hMK3-GOF
nor dMK2-LOF induce a discernable sexcomb-phenotype
by themselves or in combination with established Pc1
and ScmD1 alleles in heterozygote crosses (data not
shown). The most likely explanation for this lack of
phenotype is that dMK2 may not play a role in
anteroposterior (AP) patterning. In support of the latter,
AP-axis abnormalities have not been reported in single
or double MK2/3 knockout mice [34].
Additional files
Additional file 1: Figure S1. PRC1 target gene expression is controlled
by ERK and P38. (A). MAPK and SAPK phosphorylation in response to
mitogenic stimulation (stim) in U2-OS cells; specificity of response wassupported by distinctive phosphorylation profiles induced by two
different stressors (ETP: etoposide, Se: selenite). (B) H3S28ph and PRC1
protein (BMI1) staining in G1-arrested (starved) or mitogen-stimulated U2-
OS cells. (C) Quantification of chromatin-bound BMI1 levels (compare
Figure 1D) in mitogen-stimulated cells pretreated with kinase inhibitors
(indicated); BMI1 levels were normalized versus histone H3. (D)
Interaction of pERK and BMI1; U2-OS/BMI2Py cells were stimulated with
mitogen (stim) prior to IP; t+: longer exposure (IB: immunoblot; IP:
immunoprecipitation). Parallel experiments with pP38 were inconclusive
due to IB detection issues with applied antisera.
Additional file 2: Figure S2. PRC1/chromatin dissociation, not loss of
H3K27me3, correlates with transcription. (A) mRNA expression of PRC1
target and non-target genes in TIG3 cells upon 0, 45 and 90 min of
mitogen-stimulation. (B) Mitogenic stimulation induces BMI
phosphorylation (upper panel; pBMI1) in TIG3 cells; cellular BMI1 and
CBX8 protein (lower panel) levels remain unchanged under these
conditions in support of changed PRC1/chromatin association rather than
loss of protein (for example, degradation).
Additional file 3: Figure S3. MK3 is a negative regulator of ERK. (A)
mRNA expression of PRC1 target gene ATF3 as a function of kinase
inhibition in TIG3 cells (data as in Figure 3A) and U2-OS cells. (B)
Quantification of pERK profiles (compare Figure 3B) in control versus
MK3OE cells (left panel) and in control versus MKi cells (right panel); pERK
levels were normalized to beta Actin (b-Actin). (C-F) IB-analysis of (p)ERK
(C), (p)P38 (D), (p)JNK (E) in resting or mitogen-stimulated (stim) control
and MK-knockdown (shMK) cells and (F) in the context of MK3OE; t (min):
time post-stimulation in minutes. Samples corresponding to control (con)
and experiment (MK3OE or shMK) were always loaded on the same gel to
enable direct quantitative comparison; *: loading controls for all
corresponding panels; t+: longer exposure.
Additional file 4: Figure S4. DUSP involvement in regulation of MK3/
ERK. (A) IB analysis of ERG1 in resting or mitogen-stimulated (stim)
control (con) and MK-inhibited (MKi) cells; t (min): time post-stimulation
in minutes. Samples corresponding to control and experiment (shMK)
were always loaded on the same gel to enable direct quantitative
comparison. (B) Cells were pretreated with DUSP inhibitor (DUSPi;
concentration indicated) prior to mitogenic stimulation. IB detection of
proteins as indicated. (C) Cells were pretreated with 50 μM DUSPi prior
to mitogen stimulation. Samples corresponding to control and
experiment (MK3OE) were always loaded on the same gel (bottom panel)
to enable direct quantitative comparison. Quantitative analysis of effects
of DUSPi in control cells (con; left panel) and MK3OE cells (right panel);
normalization pERK levels was done versus beta Actin (b-Actin).
Additional file 5: Figure S5. PRC1/MK/ERK module represents a
molecular switch mechanism. (A) Functional interaction between dMK2
and Polyhomeotic in vitro: stress signaling-induced interaction of EGFP-
tagged dMK2 (Drosophila ortholog of MK2/3) and Myc-tagged Ph
(Drosophila ortholog of PHC1/2) in S2 cells. The Myc-Ph sequences
comprised the C-terminal SAM domain [54]. Conditions tested: starved,
mitogen-stimulated (FCS/TPA) and stressed (arsenite). IgG represents IgG-
heavy and -light chains. (B) Reduced dMK2 expression in third instar
v3171 larvae; normalization indicated.
Additional file 6: Table S1. Antibodies used for ChIP, ICC, IB and IP.
Additional file 7: Table S2. Primer sequences and targeting sequences.
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